Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04100408 · ClinicalTrials.gov registry record
Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)
A clinical trial of Histiocytosis, Langerhans-Cell, sponsored by Children's Oncology Group.
- Active
- Registry status
- 647
- Enrollment target
- 1
- Study location
NCT04100408 is a study of Histiocytosis, Langerhans-Cell that is active but no longer recruiting, run by Children's Oncology Group. The registered enrollment target is 647 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04100408, a study of Histiocytosis, Langerhans-Cell, is active but no longer recruiting, sponsored by Children's Oncology Group.
- ACTIVE NOT RECRUITING
- Registry status
- 647 participants
- Enrollment target
- 1
- Study location
Study Summary
The long-term goal is to define the mechanisms of pathogenesis underlying Langerhans cell histiocytosis (LCH). The overall objectives of the current study are to characterize the role of SMAD6 inherited genetic variation on LCH susceptibility and identify germline genomic regions associated with LCH somatic mutations. Building from preliminary data, the central hypotheses are: (1) causal genetic variants in SMAD6 underlie susceptibility to LCH, and (2) differences in LCH-related somatic activating mutations by race/ethnicity are related to Amerindian (i.e., Native American) genetic ancestry. The Central hypothesis will be tested by pursuing the specific aims.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
- OTHER Biospecimen Collection
Study Locations (1)
Texas
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 647 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2026-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04100408
The ClinicalTrials.gov registry entry for NCT04100408 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 647 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Histiocytosis, Langerhans-Cell appearing as the primary indexed condition, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT04100408 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04100408 about?
NCT04100408 is a clinical study titled "Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)". The long-term goal is to define the mechanisms of pathogenesis underlying Langerhans cell histiocytosis (LCH). The overall objectives of the current study are to characterize the role of SMAD6 inherited genetic variation on LCH susceptibility and identify germline genomic regions associated with LCH...
What is the current status of trial NCT04100408?
This trial is currently active not recruiting. The enrollment target is 647 participants. The study started on 2020-06-01. Estimated completion is 2026-09-30.
What conditions does trial NCT04100408 study?
This clinical trial studies the following conditions: Histiocytosis, Langerhans-Cell.
What interventions are being tested in trial NCT04100408?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER), Biospecimen Collection (OTHER).
Who is sponsoring clinical trial NCT04100408?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04100408 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Histiocytosis, Langerhans-Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.